Aurora Cannabis Sees Export Surge Led by Germany and Poland Demand
Aurora Cannabis reported Q2 2027 revenue of $86M, gross profit of $37.5M, and net loss of $21.1M. Revenue and gross profit rose 5% and 21% YOY, respectively. International medical sales surged 44% due to demand in Germany and Poland. The company will be acquired by Organigram, pending approvals, with the deal expected to close in January 2027.
How this was made
The 30-second read
Why it matters
The deal provides Aurora shareholders with a premium exit and positions Organigram to expand its market share in medical cannabis.
Market read
The acquisition is a primary corporate event likely to move both stocks and influence sector dynamics.
What to watch
Regulatory changes to Canadian medical cannabis reimbursement could affect future cash flows for both companies.
Background
Aurora Cannabis reported modest revenue growth but a sharp loss, while Organigram announced a full-share acquisition.
Ticker impact
Aurora Cannabis disclosed Q2 2027 results and announced it will be acquired by Organigram.
upward pressure on Aurora as the deal offers a premium; potential slight downside for Organigram due to financing considerations
The acquisition announcement is a primary disclosure with a clear premium, driving immediate market reaction.
Organigram Global Inc. announced it will acquire all outstanding shares of Aurora Cannabis.
slight pressure as investors assess financing and integration costs
Acquisition adds growth but also financial burden; market reaction typically mixed for the acquirer.
Market effects
Consolidation in the Canadian cannabis sector may spur further M&A activity.
Canadian cannabis stocks could see heightened volatility as the deal sets a valuation benchmark.
Limited to cannabis investors; no broad market impact.
Counterpoint
The acquisition premium may be overstated; Organigram could overpay and face integration challenges.
Key entities
- CompanyAurora Cannabis
Canadian cannabis producer reporting Q2 results and being acquired.
- CompanyOrganigram Global Inc.
Cannabis company acquiring Aurora.

